c.9253-6T > c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome

Myelodysplastic syndromes (MDS) are a heterogeneous group of hematological malignancies characterized by dysplasias, ineffective hematopoiesis and risk of acute myeloid leukemia transformation. Approximately 90% of MDS patients present mutations in genes involved in various cell signaling pathways....

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Roberta Taiane G. de, França, Ivo Gabriel. F., Junior, Howard L.R., Riello, Giovanna B.C., Borges, Daniela de Paula, Cavalcante, Gabrielle Melo, Magalhães, Silvia M.M., Pinheiro, Ronald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446231/
https://www.ncbi.nlm.nih.gov/pubmed/32682781
http://dx.doi.org/10.1016/j.htct.2020.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446231/
https://www.ncbi.nlm.nih.gov/pubmed/32682781
http://dx.doi.org/10.1016/j.htct.2020.05.006

Ejemplares similares